| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.022 | 0.6 |